Naproxen Sodium

萘普生钠

Report date: 2025/12/24 13:38:34
NME

Base Information

Drug NameNaproxen Sodium
Drug Alias NameRS-3650
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsPainFeverDysmenorrhea +[11] 
Global Approved IndicationsPainDysmenorrheaTendinopathy +[10] 
Approved Indications in ChinaPainGoutArthralgia +[4] 
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAtnahs Pharma Us Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGAtnahs Pharma Us LtdShanghai Xinyi Vientiane Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPainFeverDysmenorrhea +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A